Abstract CagriSema is a combination of amylin (cagrilintide) and glucagon-like peptide-1 (semaglutide) analogues being developed for weight management
The authors aimed to evaluate the association between pre-procedural GLP-1 RA use and post-procedural complications such as aspiration pneumonia
Talk to a Doctor About Maintenance Doses After discontinuing semaglutide, it can be beneficial to consult a doctor about maintenance doses
Allergic reaction Some people may have an allergic reaction to Lantus
Research endpoints include droplet or particle-size distribution, mucosal retention, excipient compatibility, peptide integrity, and formulation stability
Women may experience more regular cycles, temporary irregularity during active weight loss, or changes in flow